Cost Effectiveness of Fecal DNA Screening for Colorectal Cancer: A Systematic Review and Quality Appraisal of the Literature

On the basis of the available (albeit limited) evidence, while fDNA is cost-effective when compared with no screening, it is currently dominated by most of the other available screening options. Cost and test performance appear to be the main influences on cost-effectiveness. </AbstractSection> Copyright Springer International Publishing Switzerland 2013

MoreLess

Year of publication:	2013
Authors:	Skally, Mairead ; Hanly, Paul ; Sharp, Linda
Published in:	Applied Health Economics and Health Policy. - Springer, ISSN 1175-5652. - Vol. 11.2013, 3, p. 181-192
Publisher:	Springer

More details

Extent:	text/html
Type of publication:	Article
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10011000718